---
figid: PMC5785435__nihms905612f2
figtitle: 'Bevacizumab-Induced Hypertension: Clinical Presentation and Molecular Understanding'
organisms:
- NA
pmcid: PMC5785435
filename: nihms905612f2.jpg
figlink: /pmc/articles/PMC5785435/figure/F2/
number: F2
caption: Activation of VEGF receptor 2 (VEGFR2) induces cell proliferation, migration
  and survival, and vascular permeability, leading to angiogenesis. Signaling through
  phospholipase C (PLC)-γ activates protein kinase C (PKC) by the generation of diacylglycerol
  (DAG) and increases the concentration of intracellular calcium (Ca2+) via inositol
  1,4,5-triphosphate (IP3). PKC activation, increased Ca2+, and activation of the
  PI3K-Akt pathway lead to phosphorylation and activation of endothelial nitric oxide
  synthase (eNOS) and generation of nitric oxide (NO). PKC also activates the Ras/MEK/ERK
  pathway, which in turn upregulates cytosolic phospholipase A2 (cPLA2). cPLA2 releases
  arachidonic acid (AA) from phospholipids, which is acted on by cyclooxygenases (COX-1/COX-2)
  to generate prostaglandin H2 (PGH2), which is then converted to prostacyclin (PGI2)
  by prostacyclin synthase (PGIS). NO and PGI2 diffuse to adjacent smooth muscle cells,
  where NO activates soluble guanylate cyclase (sGC), leading to cGMP synthesis. PGI2
  binds to prostacyclin receptors (IP), which activate adenylyl cyclase (AC) and increase
  cAMP synthesis. cGMP and cAMP lead to decreased intracellular Ca2+ concentrations,
  which induce vasorelaxation.
papertitle: 'Bevacizumab-Induced Hypertension: Clinical Presentation and Molecular
  Understanding.'
reftext: Megan Li, et al. Pharmacol Ther. ;182:152-160.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.949461
figid_alias: PMC5785435__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC5785435__F2
ndex: 8d1196d5-def7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5785435__nihms905612f2.html
  '@type': Dataset
  description: Activation of VEGF receptor 2 (VEGFR2) induces cell proliferation,
    migration and survival, and vascular permeability, leading to angiogenesis. Signaling
    through phospholipase C (PLC)-γ activates protein kinase C (PKC) by the generation
    of diacylglycerol (DAG) and increases the concentration of intracellular calcium
    (Ca2+) via inositol 1,4,5-triphosphate (IP3). PKC activation, increased Ca2+,
    and activation of the PI3K-Akt pathway lead to phosphorylation and activation
    of endothelial nitric oxide synthase (eNOS) and generation of nitric oxide (NO).
    PKC also activates the Ras/MEK/ERK pathway, which in turn upregulates cytosolic
    phospholipase A2 (cPLA2). cPLA2 releases arachidonic acid (AA) from phospholipids,
    which is acted on by cyclooxygenases (COX-1/COX-2) to generate prostaglandin H2
    (PGH2), which is then converted to prostacyclin (PGI2) by prostacyclin synthase
    (PGIS). NO and PGI2 diffuse to adjacent smooth muscle cells, where NO activates
    soluble guanylate cyclase (sGC), leading to cGMP synthesis. PGI2 binds to prostacyclin
    receptors (IP), which activate adenylyl cyclase (AC) and increase cAMP synthesis.
    cGMP and cAMP lead to decreased intracellular Ca2+ concentrations, which induce
    vasorelaxation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Fak
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - Raf
  - Akt
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Dsor1
  - Mtk
  - Hsp27
  - aa
  - cass
  - COX1
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - Erk7
  - rl
  - COX2
  - Gycalpha99B
  - ac
  - slmb
  - Pkg21D
  - pk
  - Pc
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - KDR
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTK2
  - CRK
  - MAPK14
  - MAPK1
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - PTK2B
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - HSPB1
  - HSPB2
  - CASP9
  - BAD
  - NOS3
  - ENO4
  - PTGS1
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - EPHB2
  - MAPK3
  - PTGS2
  - PTGIS
  - SGCB
  - GUCY1A2
  - GUCY1A1
  - GUCY1B1
  - GUCY1B2
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - KLKB1
  - RIPK4
  - PC
  - Ca2+
  - Paxillin
  - CAMP
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
